- Home
- Finished Dosage Forms
- Injectables
CPHI Online is the largest global marketplace in the pharma ingredients industry
-
Products551,744
-
Companies7,781
-
Articles11,636
-
Events8
-
Webinars342
Injectables
Injectables Companies (107)
Injectables News
-
News Eli Lilly, Novo Nordisk, and Sanofi cut insulin prices by up to 78%
Insulin prices have dropped in a stark play by the three biggest makers of the product, after calls from the top of the US government.21 Mar 2023 -
News Pharmapack 2023 – Take the Start-Up innovation tour
At Pharmapack 2023 in Paris we debuted a new and improved Start-Up Hub. The Hub included several start-up companies we are looking to support and make the event more accessible.14 Mar 2023 -
News CARBOGEN AMCIS opens new liquid drug product manufacturing facility
The Switzerland-based pharmaceutical process and ingredient developer and manufacturer announced the opening of their new sterile liquid drug product manufacturing facility in France.2 Feb 2023 -
News The Biggest Drug Approvals of 2022
A carefully curated list of the most notable drug approvals of the past year, covering neurology, oncology, and COVID-19, as well as a look at the most promising drugs up for review in 2023.9 Jan 2023 -
News CPHI Frankfurt: Interview with Marcelo Cruz, Vice President, Business Development & Marketing at Tjoapack
In this series of interviews, we caught up with some of the exhibitors at CPHI Frankfurt to discover what innovations are being brought to the pharmaceutical industry this year. Here we chat with Marcelo Cruz of Tjoapack to discuss how global events ar...23 Dec 2022 -
News CPHI Frankfurt 2022: Innovator Interview – DSM Biomedical
At CPHI Frankfurt we spoke to Anne-Cecile Bayne, Global Science & Innovation Lead Pharma and Medical Nutrition, and Marc Hendriks, Vice President Strategy & Business Development, on their expertise in nitrosamines and business strategy at DSM Biomedica...23 Nov 2022 -
News Niche start-ups spearheading cell and gene therapy innovation
Smaller companies targeting rare and extremely specific treatment areas are leading the charge in this emerging market.10 Jun 2022 -
News Private equity firm to acquire CDMO CordenPharma from ICIG
Astorg has agreed to acquire the CDMO from privately-owned industrial group ICIG9 May 2022 -
News Ten23 health expands newly acquired sterile drug product manufacturing site
The expansion will provide additional cold storage and visual inspection capacity, as well as cleanrooms for device assembly and secondary packaging28 Mar 2022 -
News Packaging and Drug Delivery Trends - 5 key learning points for 2022
During the recent CPHI Webinar Packaging & Drug Delivery Trends for 2022 sponsored by Portal Instruments, experts discussed the crucial factors to consider during the development process, such as digitalisation, sustainability and a shift towards self-...14 Dec 2021 -
News ANI Pharma enhances generics and CDMO business through Novitium acquisition
The transaction expands ANI’s R&D pipeline and adds nine new customers to its growing CDMO business24 Nov 2021 -
News Hikma boosts US injectables business with $425 million deal for Custopharm
The acquisition will add 13 approved products and additional pipeline products28 Sep 2021 -
Sponsored Content Clinical & Commercial Drug Product Manufacturing: Outsourcing Advice from a CDMO
Taking a sterile drug product from clinical to commercial scale brings unique challenges. In this article, LLS Health investigates ways to mitigate scale-up challenges and achieve success.2 Sep 2021 -
News 3i Group backs ten23 health to create global CDMO focused on biopharma injectables
The new Switzerland-based CDMO differentiates itself by its sustainable vision of making a positive impact for people and planet6 Sep 2021 -
News Pharmapack interviews Serkan Oray of UCB Pharma
Ahead of Pharmapack Europe 2021 in October, we talk to one of the speakers, Serkan Oray, Vice President, Devices, Packaging & Wearable Technologies at UCB Pharma about the company's new electromechanical injection device and the innovation drive wi...16 Jun 2021 -
News Innovating in the viscosity design space with a new 2.25 mL autoinjector platform
Extending its patient-centric BD Intevia™ Disposable Autoinjector platform, BD builds on past successes while meeting the requirements of new, highly viscous, high-volume biologics for chronic diseases19 May 2021 -
News CPHI Webinar Series: Latest Approaches for Large Volume Drug Delivery
Innovation in the design and development of large volume drug delivery devices can solve the challenge of accommodating the increasing trend towards patient self-administration and home care while at the same time ensuring that drugs that require intra...26 Mar 2021 -
News Growth opportunities abound for auto-injectors amid patient-centric healthcare transition, experts tell CPHI webinar
Tremendous growth opportunities exist for auto-injectors as their value is increasingly being recognised across several therapy areas, experts have told a recent CPHI webinar, sponsored by Stevanato Group.12 Mar 2021 -
News Innovation in Drug Delivery - Part One: The trend towards self-administration
By Yifei Chen and Yasemin Bettina Karanis, IQVIA
1 Feb 2021 -
News Innovation in Drug Delivery - Part Two: Therapy area trends for injectables
By Yifei Chen and Yasemin Bettina Karanis, IQVIA1 Feb 2021
Injectables Products (288)
-
Product Small Volume Parenteral Stoppers
Our Small Volume Parenteral Stoppers (Serum Stoppers) are designed for blowback and non-blowback vials and provide optimal protection and drug delivery. Our range of pharmaceutical rubber Serum Stoppers are designed to meet multiple-piercing needs and facilitate manufacturing processes. -
Product Colistimethate sodium dry-filled vials
Colistimethate sodium is a prodrug of colistin which is a mixture of polypeptide antibiotics active against Gram-negative bacteria, including Enterobacter aerogenes, Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa.
Indication: Used in the treatment of patients with serious infectio... -
Product Prefilled Syringes
Baxter (BioPharma Solutions) offers a wide range of traditional sterile manufacturing products which includes prefilled syringes. It offers expanded small-scale through high-volume sterile manufacturing. It can increase production potential and help ensure on-time delivery to meet product demand. By provid... -
Product Finished Dosage Forms out-licensing & supply
Sandoz B2B offers a comprehensive portfolio of Finished Dosage Forms for out-licensing and supply, covering more than 20 therapeutic areas. We cover most major markets with our dossiers/marketing authorizations and are happy to discuss individual go-to market opportunities with you. Additionally, we of... -
Product Primary Packaging - Gx® prefillable syringes
Prefillable glass syringes in bulk and "ready-to-fill" format, type 1 glass, filling volumes of 0.5 ml to 5.0 ml, luer cone and luer lock syringes, needle syringes, silicone-oil reduces Gx Baked-on RTF® syringes, metal-free Gx RTF® syringes, innovative syringe components, round and cut finger flange, most ... -
Product 0,9% Sodium Chloride Injection USP
Sodium Chloride 0,9% USPAvailable in flexible container 50mL, 100mL, 250mL, 500mL, 1000mL -
Product Analytical services
West offers analytical services for specialized testing and analysis to evaluate the compatibility of drug products with their packaging or administration system for pharmaceutical and biopharma customers. -
Product Epinephrine Bitartrate (CEP / US-DMF)
Transo-Pharm Handels-GmbH offers a wide range of products which includes Epinephrine Bitartrate (CEP / US-DMF). It belongs to API category. Contact us for more information.
-
Product K-Pack® II Needles
Ready for your most challenging pharmaceutical applications K-Pack® II Needles for hypodermic injections are carefully crafted for smoother, less painful injections of today’s parenteral products. -
Product DACTINOMYCIN FOR INJECTIONS
HISUN OFFERS SUPERIOR SEVICE AND TECNICAL EXPERTISE THATS POSITION US AMONG LEADING CMOS IN CHINA , FOR FURTHER INFORMATION PLS. CONTACT [email protected] -
Product HA-SHL
・GMP certified sodium hyaluronate - powder, bio-fermentation processed. ・Molecular weight: 1,600 ~2,400 kDa. ・DMF filed in Japan, USA and China. ・CEP ・Suitable for cross-linked ・Used in pharmaceutical preparations such as for knee osteoarthritis injection, medical devices for the surgery of eye cataract,... -
Product VitiPure L 20
VitiPure L 20 is a non-ionic, hydrophilic emulsifier, co-emulsifier and solubilizer. It is an oily, yellow or brownish-yellow, clear or slightly opalescent liquid with a faint odor. VitiPure L 20 can be used in various pharmaceutical formulations. It is typically used into formulations such as Topicals (Co... -
Product Needle Isolation Technology (NIT®)
NIT® is a safety solution that eliminates the need for manual needle attachment in cartridge-based injections. It enables cartridges to be built into autoinjectors, supporting treatments beyond the 2.25 mL fill range and lyophilized drugs requiring dual-chamber containers.
Products built with NIT ... -
Product Datwyler's components for Vial applications
Datwyler is the preferred solution partner to global pharmaceutical companies. We offer one of the most extensive product portfolios for vial applications in the pharmaceutical and biotech markets worldwid. Our range of products and services includes the most innovative elastomer formulations, coatings, al... -
Product Formulation Development Services
Aurigene Pharmaceutical Services offers end-to-end formulation development services ranging from early development to clinical supplies for new chemical entities for the pharmaceutical, nutraceutical & animal healthcare industry along with life cycle extension of the products. We have the expertise alo... -
Product PFS - HA crosslinked fillers
Altergon offers pre-filled syringes of HA crosslinked. Contact us for more information. -
Product vialose trehalose dihydrate
vialose™ trehalose dihydrate is a premier performance sugar that is resistant to acid hydrolysis and enzymatic cleavage. It is used to protect and shield biologic APIs, recombinant proteins, and monoclonal antibodies (mAbs) from degradation and aggregation and to stabilize and protect valuable componen... -
Product Caspofungin
Centrient Pharmaceuticals provides wide range of drug products which includes caspofungin. Dosage form: powder for concentrate for solution for infusion. Contact us for more information. -
Product Fill-Finish
Fill-Finish Capabilities (product type) and Capacity:
Sterile liquid products
Biosafety level (BSL) 1, BSL 2 (OEL >= 10 µg/m³)
Vaccines (inactivated)
Current capacity: ~40M units/year
-
Product MEDSAMIC, Tranexamic Acid
Solution for injection or infusion 100mg/ml, 250mg/5ml, 500mg/5ml Hemostatic agent: Antifibrinolytic -
Product Injectable vials in molded glass - Clareo
Clareo, the highest quality Type II premium injection vials Clareo, the highest quality Type II premium injection vials Clareo vials are made of Type II glass and offer a combination of homogeneous wall thickness with superior cosmetic qualities suitable for high value products. Available fro... -
Product FEMAGINAL ovules
FEMAGINAL ovules based on Hyaluronic acid, Lactic Acid and Policarbophil for vaginal dryness, inflammation, infections and irritation of the vagina. (medical device Class IIa)
Women's Health / Gynaecology -
Product Meridex® PF – Dextrose (glucose monohydrate) for parenteral applications
Meridex® PF is suitable for use as an Active Pharmaceutical Ingredient in parenteral applications. Meridex® PF is endotoxin controlled and pyrogen free. It exhibits purity beyond pharmacopeia requirements and is manufactured in a cGMP certified plant in Europe. Compliance : Glucose monohydr... -
Product PolyCine APP107 Multilayer Tube
APP107 IV-bag Filling Tubes are Multilayer Polypropylene based, for TPN, Infusion, and Dialysis solution bags. -
Product INJECTA 36 - High-speed, advanced robotic processing for Ready-To-Use syringes
Enhancing the performance of advanced robotics, the INJECTA 36 raises the bar for high-speed production of Ready-To-Use syringes and pre-capped cartridges. The same cutting-edge robotic technologies assure accurate no-touch-transfer component processing with minimal operator access to the working area.... -
Product Packaging and Supply Chain Solutions
Tjoapack's packaging and supply chain solutions help our customers to make the world a healthier place. Our expert team work to facilitate your life sciences research, production and the delivery of medicines to patients across the globe.
We offer: - Packaging solutions for; oral solid blisters a... -
Product Implanters
Implants are fragile and insertion into the body requires caution. Nemera developed a portfolio of devices to deliver implants with integrated needlestick protection.
There is two types of implanters:
- Safety depot syringe with telescopic plunger rod
- Safety retro injector for ... -
Product SMART Flexi-Q eMU-P
SMART Flexi-Q eMU-P is particularly suitable for use in long-term therapies that require frequent injections, such as multiple sclerosis, autoimmune conditions and blood disorders.
The reusable design of SMART Flexi-Q eMU-P lowers cost per injection and reduces amount of materials for stor... -
Product UniSafe 1 mL
A springless, passive safety device for 1mL pre-filled syringes, designed for simple assembly and use. Simple 2-step final assembly, Secure plunger prevents removal, spillage and repeat use. UniSafe 1mL has the following benefits:
User confidence with an unobscured syringe barrel for full dose visibilit... -
Product D-Flexâ„¢ Injection Pen
D-Flexâ„¢, the pen platform for subcutaneous self-injection. Bridging the gap between fixed and variable-dose pens, this innovative product also paves the way for connected commercial devices.Just one pen for many needs: Disposable pen for fixed or multiple fixed dosagesThe versatile solution: Allows manua... -
Product Antineoplastic Formulation Injectable & Oral Solid , Propofol, General Lyophilised Injection General Lyophilised
#Propofol #Gemcitabine #Imatinib #Bleomycin #Irrinotecane #Linalidomide #Dasatinib #Abiraterone
-
Product EVER Pharma Product List
Our products include: • Atosiban • Cabazitaxel • Cebrium® • Cerebrolysin® • Dacepton® • Dexmedetomidine • Docetaxel • Fulvestrant • MemoProve® • Oxytocin • Paclitaxel • Pemetrexed • Tachyben® • Terlipressin -
Product PLACENTEX® (PDRN) tissue re-generator
WOUND HEALING ACCELERATOR PLACENTEX® - DRUGS - (PDRN) HEALING RE-EPITHELIALIZING
• Placentex® 5,625 mg / 3 ml injectable solution - 5 vials 3 ml
• Placentex® 2,25 mg / 3 ml injectable solution - 5 vials 3 ml
• Placentex® 0,75mg / 3 ml cutaneous solution - 10 via... -
Product OpHLINE - Ophthalmic Viscosurgical Devices (HA 1,4%/2%/3%)
OpHLINE is an ophthalmic viscosurgical devise (OVD) indicated as a coadjuvant during surgical procedures, involving the anterior chamber of the eye, especially in cataract surgery, including the extraction of the lens and the insertion of intraocular lenses.
OpHLINE is available in 3 models ... -
Product Buslera (Busulfan)
BUSLERA 60mg/ 10ml Vial Containing Concentrated Solution For IV Infusion
BUSLERA belongs to “alkylating agents” group of medicines, contains busulfan as active ingredient and used to clear away present bone-morrow before bone-marrow transplations. -
Product Complex Sterile Formulations Contract Development
+25 Years of accumulated experience in Lipid and polymer-based formulations.
Regarding Complex Injectables, Bluepharma's focus is on Lipid-based, polymer-based, and Long-acting injectable (LAI) formulations. Bluepharma allies the scientific expertise with the technical capability to ensure the success... -
Product IV Bags
PVC/PVC-free, Single- and Multi-chamber, customised size, configuration, injection ports and connectors.
Haemopharm is qualified as a leader in the infusion sector, thanks to a very important competitive advantage, represented with the exclusive and proprietary machinery for manufacturing of... -
Product Bonharen - Veterinary joint desease treatment
Veterinary drug, treatment of joint disease in horses and dogs. 1 % solution of sodium hyaluronate for IVN application. High efficacy, low levels of adverse reactions
-
Product CDMO Best Practices from Benches to Batches - How to Transition from Clinical to Commercial Readiness
What you need to seamlessly transition from clinical phases to commercial readiness.
Three unique abilities your CDMO must have to complete your project within your timeline are capability, flexibility and availability.
August Bioservices' Director of Customer Operations, Commercial Devel... -
Product RayDyLyo® Vial adapter
ARaymondlife has developed the essential accessory for drug reconstitution, the vial adapter, one for each RayDyLyo diameter. The RayDyLyo® vial adapter is a medical device intended for the quick and safe reconstitution of drugs, contained in vials capped with RayDyLyo® plastic press fit caps, a... -
Product Pronolis
The first High Density (HD) Hyaluronic Acid gel: Complete and innovative range of viscosupplementation. Medical Device Class III
• High quantity of hyaluronic acid, up to 120mg per syringe • High concentration, for a fast and prolonged pain relief • Unique Mono-shot HD hyaluronic acid specificificall... -
Product Components for syringes
Our pre-fillable syringes form a complete system when combined with the plunger rods and stoppers, the needle guard and finger rest enlargement. Especially the finger rest enlargement leads to more safety and user-friendliness. Thanks to our usability engineering, we manufacture piston rods and fin... -
Product CordenPharma Peptides Platform
Your Expert Partner for Peptide APIs
• >> Proven track record delivering world class manufacturing services from early stage to commercial supply, including complex products (e.g., Linaclotide, Enfuvirtide, Mifamurtide, Eptifibatide, Glatiramer, GLP analogues). • >> Proprietary... -
Product Amikacin Inj.Sol 500mg/2ml (EU CTD Available) & 1g/4ml (EU CTD Available: Q3 2021)
Amikacin Solution for Injection
Reference Product: Briklin® / BRISTOL-MYERS SQUIBB
Description: Amikacin sulfate is indicated in the short-term treatment of serious infections due to susceptible strains of Gram-negative bacteria, including Pseudomonas species,&nb... -
Product OSTENIL®
OSTENIL® is a solution containing hyaluronic acid for injection into the joint cavity.
OSTENIL® is indicated for the treatment of symptoms of osteoarthritis. It has been shown to reduce pain and stiffness in the affected joint and to improve joint function
Pre-filled syringe to relieve pain in... -
Product Blow Fill Seal
Curida offers contract manufacture of liquid pharmaceuticals in Blow Fill Seal ampoules, -
Product Dexmedetomidine HCl Injection
Dexmedetomide HCl is an anxiolytic, sedative, andanalgesic medication.
Strength: 200mcg/2ml (100mcg/ml); Single-dose Vial
This product has been approved by CFDA and US-FDA.
Strength: 80mcg/20ml; 200mcg/50ml; 400mcg/100ml
This product has been app... -
Product Haemostop
Indications
Control of haemorrhage associated with severe fibrinolysis in haemorrhagic disease, haemoptosis, after operations or tooth extraction
Each ml of HAEMOSTOP 250 mg injection contains:
Tranexamic Acid ……….. 50 mg
Each ml of HAEMOSTOP 500 mg inject... -
Product Docetaxel AqVida 20 mg/ml concentrate for solution for infusion
20 mg, 80 mg, 140 mg, 160 mg vial Indications: Treatment of breast cancer, special form of lung cancer, prostate cancer, gastric cancer and head or neck cancer -
Product Hospital Products for USA and/or Canada
Methapharm is your strategic partner to bring your hospital and specialty products to market in the USA and/or Canada. Part of the ACIC Group, Methapharm is focused on the acquisition, development, licensing, and promotion of hospital and specialty pharmaceutical products as well as products in... -
Product Dual-Mix® Flexible Bags - Innovative Error-free System for Drug Reconstitution
Technoflex has developed Dual-Mix ®, an innovative primary packaging which meets three challenges: storing the medicine to be reconstituted (powder or lyophilizates) and its diluent, making its reconstitution secure and ensuring the safety of healthcare staff and the patient. • Ready-to-Use • Peel... -
Product Biopass
BIOPASS ensures a smooth preparation of injectable medications. The BIOPASS system allows to reconstitute lyophilized drugs in a very convenient way. This user-friendly reconstitution system supports patients and caregivers for self-administration -
Product Oval Shaped PE Containers
Vioser provides a wide variety of pharmaceutical products and medical equipment which includes oval shaped PE containers. It is produced using the bottlepack system of blow-fill-seal technology. Features: Twin port closure system for infusion and additions, non fragile, easy to store, cost-effective, long ... -
Product 1% Lidocaine HCl Injection, USP
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212821 -
Product Acyclovir sodium sterile
Acyclovir Sodium Injection is a synthetic nucleoside analog, active against herpes viruses. It is a sterile, aqueous solution for intravenous infusion, Ayclovir Sodium Injection is a synthetic nucleoside analog, active against herpes viruses.
Acyclovir Sodium is the sodium salt form of a... -
Product Aripiprazole LAI
Pharmaceutical form: Long acting injectable. Therapeutic category: Treatment of schizophrenia.
Strengths: 300mg/vial & 400mg/vial ,300mg/syringe & 400mg/syringe.
Contact us for more information.
Products which are subject to patent protection are currently not offered or ... -
Product Aenova Sterile Fill Finish & PFS manufacturing
The Aenova Group is a premier solution partner for sterile dosage forms with 3 FDA approved facilities offering high quality injectables for human health and animal health products.
Our Sterile services include specialized capabilities for:
Beta-lactams (penicillins, cephalosporins)In... -
Product Drug Product Manufacturing
Ajinomoto Bio-Pharma Services is an established premier CDMO for large, medium, and small molecule APIs offering a unique range of formulation and aseptic filling in vials, prefilled syringes and cartridges to address production needs that span from clinical to commercial phase products. Our global netw... -
Product GLUTHION
600 mg injectable powder and solvent box of 10 vial plus 10 solvent ampoules. API: Gluthation -
Product Cloxacillin inj 1g & capsules 500 mg
Reig Jofre Group offers wide range of pharmaceutical products which includes anaclosil. Packaging: anaclosil 500 mg capsules, 500 cap. E.c, anaclosil 500 mg capsules, 20 capsules, anaclosil 500 mg capsules, 40 capsules, etc. -
Product Injectable Anaesthetics
Sintetica SA offers wide range of products which includes injectable anaesthetics. Contact us for more information. -
Product PremiumCoat® ETFE Film Components
Aptar Pharma’s PremiumCoat® is a range of ETFE (Ethylene Tetrafluoroethylene) coated stoppers and plungers based on an approved, pure, state-of-the-art elastomeric formulation. Providing a combination of container closure integrity and improved compatibility, PremiumCoat® offers the highest standard l... -
Product Vancomycin Injection, Ready to Use
Vancomycin hydrochloride is a glycopeptide antibiotic active against a wide variety of Gram-positive bacteria, most important being staphylococci, such as Staphylococcus aureus and Staphylococcus epidermidis (including susceptible methicillin-resistant strains), but also active against corynebacterium, ent... -
Product Colistimethate sodium lyophilized vials
Colistimethate sodium is a prodrug of colistin, which is a mixture of polypeptide antibiotics active against Gram-negative bacteria, including Enterobacter aerogenes, Escherichia coli, Klebsiella pneumoniae and especially Pseudomonas aeruginosa.
Indication:&nbs... -
Product Polymyxin B vials
Polymyxin B is a mixture of the sulfates of polypeptide antibiotics active against Gram-negative bacteria.
Indication: Used in the treatment of patients with acute urinary, meningeal or blood-stream infections due to susceptible strains such as Pseudomonas aerugino... -
Product Voriconazole vials
Voriconazole is a broad spectrum triazole antifungal agent.
Indication: Used in the treatment of patients with progressive, possibly life-threatening fungal infections such as candidaemia in non-neutropenic patients, invasive candidiasis in skin, abdomen, kidney, bladd... -
Product Micafungin vials
Micafungin is a semisynthetic lipopeptide from the echinocandin class of antifungal agents. Micafungin is active against most isolates of the following Candida species such as Candida albicans, Candida glabrata, Candida guiliermondii, Candida krusei, Candida parapsilosis and Candida tropicalis.
... -
Product Daptomycin
Daptomycin is a lipopeptide antibiotic active against Gram-positive bacteria such as Staphylococcus aureus (including methicillin-resistant isolates), Streptococcus pyogenes, Streptococcus agalactiae, Streptococcus dysgalactiae subsp. equisimilis, and Enterococcus faecalis (vancomycin-susceptible isol... -
Product Gx RTF® metal-free glass syringes
One problem associated with syringe use is that traces of tungsten or other metals occasionally leave residue behind in the bore when the syringe cone is shaped. Gerresheimer developed a production technology registered for patent where the pin used to shape the cone is made of a special ceramic. So we can... -
Product Epirubicin HCl (CEP / US-DMF)
Transo-Pharm Handels-GmbH offers a wide range of products which includes Epirubicin HCl (CEP / US-DMF). It belongs to API category. Contact us for more information. -
Product Idarubicin HCl (ASMF / US-DMF)
Transo-Pharm Handels-GmbH offers a wide range of products which includes Idarubicin HCl (ASMF / US-DMF). It belongs to API category. Contact us for more information. -
Product K-Pack® Surshield™ Needles with passive sharps protection
K-Pack® Surshield™ Needles for hypodermic injections with passive sharps protection offer a hypodermic needle with integrated needlestick prevention supporting both therapeutic success and and reduction of the transmission risk induced by needle stick injuries at the same time. -
Product PLAJEX™ Ready-to-Fill Polymer Syringe with Tapered Needle
PLAJEX™ Ready-to-Fill Polymer Syringes with Tapered Needles offer the better injectability without compromising patient comfort for pharmaceutical manufacturers who need to overcome injectability problems associated with highly viscous concentrated formulations.
(Assessment of the Injection Performa... -
Product SurGuard®3 Safety Hypodermic Needles
Designed for convenient one-handed activation, SurGuard®2 Safety Hypodermic Needles offer a simple needlestick protection solution combined with advanced cannula and tip technologies. -
Product SurGuard®3 Safety Hypodermic Needles
Equipped with Terumo’s patented three-way activation shield design, precision manufactured cannula and triple-bevel lancet, SurGuard®3 Safety Hypodermic Needles are carefully crafted to suit clinicians’ needs and assure patient comfort. -
Product Neolus® Needles
Neolus® Needles for hypodermic injection offer drug product manufacturers a high performance single-use needle solution ready for today's parenteral formulations. -
Product DAPTOMYCIN FOR INJECTION
HISUN OFFERS SUPERIOR SEVICE AND TECNICAL EXPERTISE THATS POSITION US AMONG LEADING CMOS IN CHINA , FOR FURTHER INFORMATION PLS. CONTACT [email protected] -
Product DAUNORUBICIN FOR INJECTION
HISUN OFFERS SUPERIOR SEVICE AND TECNICAL EXPERTISE THATS POSITION US AMONG LEADING CMOS IN CHINA , FOR FURTHER INFORMATION PLS. CONTACT [email protected] -
Product DOXORUBICIN FOR INJECTION
HISUN OFFERS SUPERIOR SEVICE AND TECNICAL EXPERTISE THATS POSITION US AMONG LEADING CMOS IN CHINA , FOR FURTHER INFORMATION PLS. CONTACT [email protected] -
Product KANAMYCIN FOR INJECTION
HISUN OFFERS SUPERIOR SEVICE AND TECNICAL EXPERTISE THATS POSITION US AMONG LEADING CMOS IN CHINA , FOR FURTHER INFORMATION PLS. CONTACT [email protected] -
Product TIGECYCLINE FOR INJECTION
HISUN OFFERS SUPERIOR SEVICE AND TECNICAL EXPERTISE THATS POSITION US AMONG LEADING CMOS IN CHINA , FOR FURTHER INFORMATION PLS. CONTACT [email protected] -
Product VitiPure O 80 LEX
VitiPure O 80 is a non-ionic, hydrophilic emulsifier, co-emulsifier, solubilizer and suspension stabilizer used widely in various biopharmaceutical formulations. It appears as amber liquid in room temperature with a faint characteristic odor. VitiPure O 80 has a broad working pH range and offers good skin ... -
Product Large-volume & high-viscosity drug delivery solutions
SHL offers a versatile range of autoinjectors and wearable systems that enable the delivery of protein biologics for larger fill volumes and liquid viscosities. These systems are designed to help our customers bring their innovative treatments to the hands of patients.
Products: • Bertha®: 2-step a... -
Product Molly® Modular Platform Autoinjector
Molly is a single-dose autoinjector technology developed to help pharma and biotech companies reduce initial investments and expedite development timelines. Built on a proven modular platform, Molly reduces risks during the development process while increasing flexibility in device design and production. A... -
Product Datwyler's solutions for Prefilled Syringe applications
We offer our customers a broad portfolio of the highest quality sealing solutions for their syringe systems. This includes elastomeric plunger stoppers, needle shields, and tip caps to seal the prefilled syringes as well as plungers and rubber-lined aluminum seals to ensure system integrity. -
Product Datwyler's wide range of Cartridge components
As a reliable supplier of sealing solutions for sensitive drugs, we offer an extensive product portfolio in cartridge applications. With this broad offering, we can make an important contribution to a variety of pharmaceutical and biotech therapies, such as dental care and insulin management. Our priority ... -
Product VitiPure HCO 40
VitiPure™ HCO 40 is versatile solubilizer and emulsifier enhancing the solubility and bioavailability of hydrophobic APIs and vitamins. It complies with USP (Polyoxyl 40 Hydrogenated Castor Oil) and Ph. Eur. (Macrogolglycerol Hydroxystearate). -
Product VitiPure CO 35
VitiPure™ CO 35 Solubiliser and emulsifying agent for the human and veterinary pharmaceutical industries. It complies with USP (Polyoxyl 35 Castor Oil) and Ph. Eur. (Macrogolglycerol Ricinoleate). Improves bioavailability of APIs when used in self-emulsifying systems. -
Product VitiPure LEX 300/VitiPure LEX 400
VitiPure™ LEX 300 & 400 are lower molecular weight Polyethylene glycol with stringent control of microbial load for pharmaceutical Industry. These products surpass the current pharmacopoeia requirements and support the needs of customers for high risk applications. They are safe and wid... -
Product VitiPure LEX 300/VitiPure LEX 400
VitiPure™ LEX 300 & 400 are lower molecular weight Polyethylene glycol with stringent control of microbial load for pharmaceutical Industry. These products surpass the current pharmacopoeia requirements and support the needs of customers for high risk applications. They are safe and wid... -
Product HA-QSE
・GMP certified extra-high molecular weight sodium hyaluroniate powder extracted from chicken comb. ・Molecular weight: 1,900 ~ 3,900 kDa ・DMF filed in Japan and South Korea ・Used in pharmaceutical preparations such as for knee-osteoarthritis injection, medical device for the surgery of eye cataract, preven... -
Product HA-AM
・GMP certified sodium hyaluroniate powder extracted from chicken comb. ・Molecular weight: 600~1,200 kDa ・DMF filed in Japan, USA, China and South Korea ・Used in pharmaceutical preparations such as for knee-osteoarthritis injection, (dry) eye drops, medical device for the surgery of eye cataract, preventio... -
Product Injectable vials in molded glass - EasyLyo
EasyLyo offers a stronger vial that is more resistant and
suitable to extreme conditions encountered during the
lyophilization process.
EasyLyo is a range of Type I glass vials specifically
designed to answer the growing demand for smaller
capacity vials.
Avail... -
Product Injectable vials in molded glass - Sterinity
SGD Pharma partnering with SG Ompi EZ-fill® to offer washed, sterilized and depyrogenated high-quality
Type I molded glass vials.
A secondary packaging designed in collaboration with the highest quality machine suppliers and optimized to:
· Grant the vial sterility until the... -
Product Injectable vials in molded glass - Clareo
Clareo vials are made of Type II glass and offer a
combination of homogeneous wall thickness with
superior cosmetic qualities. The range offers technical
characteristics similar to the vials in the existing range
and can replace them without any regulatory change.
With Clareo, SGD ... -
Product Injectable vials & Ampoules in tubular glass
SGD Pharma India tubular vials and ampoules are made of neutral borosilicate glass from the 5.0 expansion
coefficient family. The tubular glass used by SGD Pharma India is supplied by globally renowned glass tubing
manufacturers like Schott, NEG, Corning and others as per the specific... -
Product Levocarnitine HCl (also as MA)
ampoules 1g/5ml
ampoules 2g/5ml
oral solution 1g/10ml
oral solution 2g/10ml
-
Product Methylprednisolone sodium succinate (only as MA)
vials 20mg/2ml
vials 40mg/2ml
vials 120mg/2ml
vials 500mg
-
Product Lyomax
LYOMAX, Industrial Freeze Dryer
The freeze-drying process of today demands increased process control, with reduced processing time augmented with upgrades in equipment to remain compliant with a changing regulatory landscape. To accommodate such growth, IMA LIFE uses its in-depth process... -
Product Vega
VEGA: Rotary washing machine
Vega is a washing machine for bottles, vials, ampoules and unstable cylinder-shaped containers. Born to satisfy the most stringent market requirements, it is available in four different models featuring a continuous rotary motion to reach very high speeds while... -
Product Sensitive AP400 CW
SENSITIVE AP400 CW
Carton labelling machine with 100% check weighing system
The SENSITIVE AP400 CW is one of the latest developments in the field of carton labelling. Integrated with a 100% check-weighing system, it is conceived to apply labels onto three of the carton’s sid... -
Product Xtrema
XTREMA, High Speed Filling and Stoppering Machines for Aseptic Environments
XTREMA fundamental characteristics respond to the industry’s stringent technical requirements of vial filling, and with its flexible and ergonomic design it assures the most complete possibility to integrate mod... -
Product UniSafe 2.25 mL
UniSafe® 2.25 is the latest addition to Owen Mumford Pharmaceutical Services’ UniSafe® platform. Designed for higher volume and higher viscosity drugs, UniSafe 2.25, like the on market 1 mL version, has a unique spring-free design and integrates critical safety features. UniSafe 2.25 is intuitive... -
Product Meropenem 500mg, 1000mg and 2000mg
We are offering Meropenem in 3 dosage forms- 500mg, 1000mg and 2000mg. Its one of our prime product. Kindly connect for association. -
Product Atosiban
Atosiban is an inhibitor of the hormones oxytocin and vasopressin. It is used as an intravenous medication as a labour repressant (tocolytic) to halt premature labour. Atosiban EVER is indicated to delay imminent pre-term birth in pregnant adult women with a gestational age from 24 until 33 completed weeks... -
Product CONDROTIDE® HA - POLYNUCLEOTIDES-HPT® AND HA FOR INTRA ARTICULAR INJECTIONS
• ORTHOPEDICS - Class III MD CONDROTIDE® HA is the only Polynucleotide (PN) and Hyaluronic Acid (HA) based product available on the market for osteoarthritis treatments. This gel acts as a lubricant and helps to normalize the viscosity of the synovial fluid
- Sterile, pre fil... -
Product CONDROTIDE® (POLYNUCLEOTIDES-HPT® GEL - 2ML)
INTRA-ARTICULAR INJECTIONS OF POLYNUCLEOTIDESFOR THE TREATMENT OF OSTEOARTHRITIS
40 mg/2ml of polynucleotides
Sterile, pre-filledglass syringe, for single use -
Product PLINEST® LINE (Gel/Fast/Eye/Hair/One) - POLYNUCLEOTIDES - HPT® FOR BIOREVITALIZATION TREATMENTS
PLINEST® line: five formulations of polynucleotides gel, for aesthetic medicine treatments (intradermal infiltrations)
Plinest® Gel 20 mg/ml 2 ml - PFS
Plinest® Fast 7,5 mg/ml - 2 ml - PFS
Plinest® Hair 7,5 mg/ml - 2 ml - PFS
... -
Product NEWEST® LINE - POLYNUCLEOTIDES - HPT® + HA FOR SKIN BIOREVITALIZATION TREATMENTS
- NEWEST® (Polynucleotide and Hyaluronic Acid) - 10+10 mg/ml - 2 ml - pre-filled syringe- NEWEST® ONE (Polynucleotide and Hyaluronic Acid) 1 + 1 mg/ml - 4 ml - 5 Vials -
Product Azacitidine EVER Pharma
Azacitidine is a cytotoxic hypomethylating chemical analogue of cytidine used in the treatment of myelodysplastic syndromes.
Azacitidine EVER Pharma is available in both the standard 100 mg vial size and a new 150 mg vial size aligned to the most common patient doses to minimize waste... -
Product Bortezomib EVER Pharma
Bortezomib is a protease inhibitor indicated for the treatment of progressive or untreated multiple myeloma, and mantle cell lymphoma.
Bortezomib EVER Pharma is provided as a ready to useformulation for subcutaneous injection (SC), and afterdilution for intravenous injection. -
Product TrHLINE - Joint injections (linear HA 1%/2%)
TrHLINE is a linear hyaluronic acid injection, designed for intra-articular administration to restore the viscoelastic properties of synovial fluid in traumatic and degenerative lesions of the joints, manifested by pain syndrome and reduced mobility.
TrHLINE is available in 2 models with ... -
Product BtHLINE - Dermal filler for biorevitalization (linear HA 1,4%)
BtHLINE is a biocompatible linear hyaluronic acid hydrogel intended as a dermatologicaltreatment for aesthetic purposes. Administered by intradermal injection, the product is indicated to complement the extracellular matrix and intradermal tissue, restoring the anatomical structures of the skin, promot... -
Product ADAPTEK® TECHNOLOGY
ADAPTEK® TECHNOLOGY is the general name for our 4 international patents and expertise in nanotechnology and controlled release systems.This is a transversal technology that allows to develop customized biopolymeric nanohydrogels, allowing the load with different API (drugs, vitamins, growth factors, etc.).... -
Product TrHCROSS - Joint injections (cross-linked HA 2%)
TrHCROSS 2% is a biocompatible hydrogel of cross-linked sodium hyaluronate obtained by biofermentation. This is a single injection, designed to relieve joint pain in osteoarthritis by replacing natural joint fluid and replenishing lubricating and shock-absorbing functions.
Properties
... -
Product Biemparin (Heparin Sodium)
BİEMPARİN 25000 IU/5 ml vial containing solution for I.V., S.C. injection
BİEMPARİN belongs to a group of anticoagulant medicines named as heparin sodium. -
Product Biemexol 350 mg - 300 mg (Iohexol)
Iohexol 350 mgI/mL Solution for Injection50,100 or 200 ml Vial / Per Box
-
Product Gadonans (Gadobutrol)
Gadonans (Gadobutrol) 7,5 / 15 and 30 mL
GADONANS is a contrast agent that is administered into the vein in magnetic resonance imaging only for diagnostic purposes. Magnetic resonance imaging is obtained by viewing the behavior of water molecules in normal and abnormal tissues. -
Product D-Flex™ Injection Pen
D-Flex™, the pen platform for subcutaneous self-injection. Bridging the gap between fixed and variable-dose pens, this innovative product also paves the way for connected commercial devices.
• Just one pen for many needs: Disposable pen for fixed or multiple fixed dosages • The versatile solution: All... -
Product Connected Solutions
D-Flex™ Logbook – From data to value
The D-Flex™ Logbook collects treatment data at the point of care, without the need for a patient app or mobile phone. The D-Flex™ Logbook consists of the disposable D-Flex injection pen and the connected cap, which replaces the standard cap of the pen. Patients rem... -
Product NEW! Fillchoice® Refill KIT
A Ready-to-Transfer CSTD for drug reconstitution and administration to the patient from one or multiple drug vials.
• PATENDED In routine clinical practice of drug reconstitution, health care workers are at serious risk from the use of syringes with needles and exposure to the potential release o... -
Product Food Supplements
We develop and produce food supplements in these pharmaceutical forms:
Tablets
Syrups
Drops
Oils
Capsules
Sachets
Vials
Soft Capsules
Stick pack -
Product Medical Devices based on substances
We develop and produce medical devices based on substances of class I, IIa and III.
In particular:
Oral Spray
Nasal Spray
Ear Spray
Ear Drops
Oral drops
Oral solids (tablets and sachets)
Vaginal Ovules
Vaginal washes
Eye drops (single an... -
Product Azithromycin Pd.Sol.Inf 500mg/Vial (EU CTD Available)
Azithromycin 500mg/Vial Powder for Solution for Infusion Reference Product: Zithromax® / PFIZER
Description: Azithromycin as powder for solution for infusion is indicated for the treatment of community-acquired pneumonia due to susceptible microorganisms in adult patients where initial intrav... -
Product Brivaracetam Sol. Inf 10mg/ml (5ml Vial) (EU CTD Available: Q3 2022)
Brivaracetam 10mg/ml (5ml Vial) Solution for Injection/Infusion
Reference Product: Briviact® / UCB
Description: Brivaracetam is an antiepileptic agent which is indicated as adjunctive therapy in the treatment of partial onsetseizures with or without secondary generalization in adults, adolescents and... -
Product OSTENIL® mini
OSTENIL® mini is indicated for the treatment of symptoms of osteoarthritis in small synovial joints such as the carpometacarpal joint of the hand, the ankle joint, the temporomandibular joint and the facet joint of the spine. OSTENIL® MINI: pre-filled syringe to relieve pain induced by osteoarthritis.... -
Product OSTENIL® Plus
OSTENIL® PLUS is a unique combination of natural high dose HA (2%) + mannitol.
The formulation offers the possibility of reducing the number of intra-articular injections and increasing the intervals between injections. OSTENIL® PLUS: pre-filled syringe to relieve pain induced by ... -
Product OSTENIL® Tendon
OSTENIL® TENDON was developed to treat pain and restricted mobility in tendon disorders. It is a conservative treatment based on the biomechanical properties of hyaluronic acid.
OSTENIL® TENDON is injected into the tendon sheath (intrasheath injection) or around the affected tendon (peritendinous i... -
Product Ondavell
Ondavell contains Ondansetron, which belongs to antiemetics category. It manage nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. Available in tablets (4 mg and 8 mg) and solution for injection (2 mg/ml, in 2 volumes 2 ml & 4 ml). -
Product Xevolac
Indications
Short term management of moderately severe, acute pain following surgical procedures
Each ml of XEVOLAC injection contains:
Ketorolac Tromethamine…10 mg
Each ml of XEVOLAC injection contains:
ketorolac Tromethamine….30 mg
Packaging: qq... -
Product Epirubicin AqVida 2 mg/ml solution for injection
10 mg, 20 mg, 50 mg, 100 mg, 200 mg vialIndications: Treatment of breast cancer, advanced ovarian cancer, stomach cancer, small cell lung cancer, bladder cancer -
Product Irinotecan AqVida 20 mg/ml concentrate for solution for infusion
40 mg, 100 mg, 300 mg vial Indications: Treatment of advanced colorectal cancer -
Product Inerta® Flexible Bags - Guaranteeing Drug Preservation Until Administration
The proven and recognized chemical inertia of the Inerta® polypropylene bags simplifies the packaging of drug solutions in a reliable, tried and tested container. Inerta® bags* are fully compliant with the requirements of European and American pharmaceutical regulations. They meet customer require... -
Product Datapen
Datapen is a smart reusable injector pen adapted to chronic disease treatments and connected to a mobile app.
The solution records each dose injected, with specific time and date, and send the information back to the smartphone via Bluetooth technology.
Compatible ... -
Product IV Solutions
Vioser provides a wide variety of pharmaceutical products and medical equipment which includes IV solutions. Contact us for more information. -
Product VINKABLAST 10mg/10ml( Vinblastine Injection )
Vinblastine 10mg/10ml injectionStore in 2-8 degree C -
Product 0.75% Bupivacaine HCl in 8.25% Dextrose Injection, USP
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212822 -
Product Humia Injection (Hyaluronic Acid 60mg/3mL - cross liked HA) for osteoarthritis
Intra-articular, single-shot injection of hyaluronic acid in knee osteoarthritis
Your body makes hyaluronic acid. It's a natural part of the fluid that helps lubricate and cushion your joints and keeps them working smoothly.When you have osteoarthritis (OA), the hyaluronic acid in t... -
Product Dental Anesthesia
Lidocaine HCl 2% with Epinephrine 1:100,000 Inj.
Lidocaine HCl 2% with Epinephrine 1:80,000 Inj.
Articaine HCl 4% with Epinephrine 1:100,000 Inj.
-
Product August Bioservices - End to End (Preclinical to Clinical to Commercial), US-based CDMO Capabilities
This is an overview capabilities brochure of the services and expertise August Bioservices offers to biotech and pharma companies of all sizes. As a growing, US-based provider of expert CDMO services, August is rapidly becoming a preferred partner for clients seeking deep drug development, formulation, sca... -
Product Voriconazole 200 mg powder and solvent for solution for infusion
Contact us for more information. -
Product Teicoplanin 200 mg, 400 mg Lyophilized Powder for Injectable Solution
Contact us for more information.
-
Product Pantoprazole 40 mg Lyophilized Powder for Solution for Injection
Contact us for more information.
-
Product Regivell
Indications
Spinal anaesthesia for surgery (urological and lower limb surgery lasting 2-3 hours,
abdominal surgery lasting 45-60 minutes).
Each mL Regivell Spinal 0.5% Heavy contains :
- Bupivacaine HCl Monohydrate equivalent with Bupivacaine HCl 5 mg
- Dextrose Monohydra... -
Product Acetonitrile
A highly pure solvent used as an Excipient in Oncology Injectable formulations such as Bortezomib, Doxorubicin etc.
Specification:
USDMF -
Product Acetic acid glacial
Acetic acid glacial is widely used as a pharmaceutical excipient in various formulations as a pH modifier and preservative.
Specification : USP, Ph.Eur, BP, IP, JP -
Product Acetone
Acetone is widely used as a pharmaceutical excipient in various formulations as a solubilizing agent and solvent. It can be utilized in formulation development of Solid orals (including Microspheres, Microcapsules, Spray drying) and other NDDS formulations.
Specification: USP-NF, Ph.Eur, BP... -
Product Extractable & Leechables
Our extractable and leachable services include:• Design, develop and execute the E&L study for pharmaceutical industry according to the variousregulatory guidelines and recommendations such as USFDA (USP <1663> and <1664> General Chapters),EMA, PQRI, ICH and/or customer requirements.• Selec... -
Product Huons Injectable Solution Preparations (SFI)
Anesthetics Injection Products General Injection Products Well-Being Injection Products
Various Injectable Solution Preparations are capable to manufacture. Looking for a global partner who can properly deal with our products to make good sales together.
Specifically recommends:
<Anesthe... -
Product Huons Dental Cartridges
Lidocaine HCl 2% + Epinephrine 1:100,000 Inj. Lidocaine HCl 2% + Epinephrine 1:80,000 Inj. Articaine HCl 4% + Epinephrine 1:100,000 Inj.
Cartridge Ampoule packed Dental Anesthetics
Currently exporting to more than 30 countries in the world.
Looking for a capable importer/distributor with... -
Product Negaban® / Temopen®
Negaban® / Temopen®
MoleculeTemocillin Disodium Therapeutic DomainInfectious Disease -
Product Walk in Cooling Cabinet.
The Walk-In Cooling Cabinets / cold rooms are designed according to ICH guidelines, WHO, MCA and USFDA requirements to maintain uniform conditions. They are superior in airflow distribution, temperature control technology, cabinet construction and are manufactured as per cGMP regulations.
Biggest Walk... -
Product Fentanyl Citrate Injection USP 50mcg/ml, 2ml
Fentanyl is an opioid analgesic used:
- in low doses to provide analgesia during short surgical procedures.
- in high doses as an analgesic/respiratory depressant in patients requiring assisted ventilation.
- in combination with a neuroleptic drug as part o... -
Product CDMO
• Cytotoxic Injection (Liquid , Lyophilized) • ONCOLOGY • CYTOTOXIC API • EU GMP • JGMP (Japan) • KGMP (Korea) • PIC/S -
Product FPFs
• Genexol®PM Inj.(Paclitaxel) • Genexol® Inj.(Paclitaxel) • Nanoxel®M Inj.(Docetaxel) • Docetaxel Inj.(Docetaxel) • Nexatin® Inj.(Oxaliplatin) • Everose® Tab.(Everolimus) • Pemed®S Inj.(Pemetrexed) • Azalid® Inj.(Azacitidine) • Decilid® Inj.(Decitabine) • Lenalid® Inj.(Lenalid... -
Product Dexmedetomidine Injection
100 mcg/ml - 2 ml Dexmedetomidine injection for ICU sedation and procedural sedation -
Product Clodronic Acid and Lidocaine Injection
50mg/ml + 10mg/ml injection for the treatment of osteoporosis, hypercalcemia of malignancy and osteolysis -
Product Ephedrine Injection
3 mg/ ml, 10 mg/ ml & 30 mg/ ml injection for the management of anaesthesia induced hypotension -
Product ATB-301
[TGF-β2 Targeting ASO (TASO) + IL-2 Combination therapy] - Phase Ib
1. Confirm the potential of TGF-β2 as a biomarker in human blood and tumor tissues from the efficacy result of Phase Ib clinical trial on cancer patients
2. Confirm the suppression of IL-2’s side effect in combinati... -
Product Biolevox™ Tendon
Biolevox™ HA Tendon is a hyaluronic acid administered around the tendon or into the tendon sheath. Biolevox™ HA Tendon is a gel with an optimal concentration of 1.6%, volume of 2 ml and molecular mass.Biolevox™ HA Tendon can reduce the level of perceived pain and leads to a substantial recovery of the func... -
Product Biolevox™ HA intraarticular injections
Biolevox™ HA is a line hyaluronic acid gels for an intraarticular injections in pre-filled syringes. Sodium hyaluronate obtained by bacterial fermentation is used as a viscoelastic gel in osteoarthritic joint. Hyaluronic acid role in joint is to facilitate the joint movement, relief pain, protect intra-art... -
Product Tramadol HCl
Grünenthal GmbH offers a selected range of products which includes Tramadol HCl, as API, bulk and/ or finished dosage form. Please contact us for more information.
-
Product Paliperidone Palmitate Long Acting Injection (Under development)
Ingridient: Paliperidone Palmitate
Dosage form: Lyophilized long acting injection (monthly)
Indication: Treatment of schizophrenia in adults and treatment of schizoaffective disorder in adults as monotherapy and as an adjunct to mood stabilizers or antidepressants. -
Product DORIPRO - DORIPENEM 500 MG INJECTABLE
Doripenem injection is used to treat serious infections of the urinary tract, kidney, and abdomen that are caused by bacteria. Doripenem injection is in a class of medications called carbapenem antibiotics. -
Product CUZIT-L - AZITHROMYCIN 500 MG INJECTABLE
Azithromycin is an antibiotic medication used for the treatment of a number of bacterial infections. This includes middle ear infections, strep throat, pneumonia, traveler's diarrhea, and certain other intestinal infections. -
Product CURIONIC - HCG 5000 IU INJECTABLE
Human chorionic gonadotropin is a hormone for the maternal recognition of pregnancy produced by trophoblast cells that are surrounding a growing embryo, which eventually forms the placenta after implantation.
Injectable Pharmaceuticals
Injectable pharmaceuticals are drug product delivery systems that can be used as an alternative to oral drugs and are more effective because of how fast they work. Injectable pharmaceuticals are passed into the human body through syringes to the bloodstream and other parts of the body. Unlike oral drugs, injectable drugs do not get dismantled in the stomach and are not altered by digestive enzymes. There are several benefits of injectable pharmaceuticals, and that is why many biotech companies and big pharmaceuticals are keying into the many opportunities in this industry.
What are the top companies that manufacture injectable pharmaceuticals?
There are many existing companies and vendors and a lot more coming up with new syringe technology ideas. Quality, financial capacity, knowledge, and experience of the industry are all key parameters in which to judge an injectable manufacturing company.
It is almost impossible to make mention of injectable pharmaceuticals without referencing Pfizer. In 2015, the company completed its buyout of Hospira, a biosimilar company and one of the top suppliers of generic injectable drugs such as anesthesia, oncology, cardiovascular, and anti-ineffective therapies.
Other big names are Hikma, Sagent and Novartis.
What are the main challenges of manufacturing injectable pharmaceuticals?
While many patients find injectable pharmaceuticals more effective than oral medicine, injectable drugs are less convenient for patients, raising issues of adherence, even for those that are in chronic conditions.
The quest for different delivery methods is another challenge even though it is being managed with the recent growth of the global injectable drug delivery market. Patients, regardless of their state, want convenience and as a result, manufacturers are faced with the challenge of meeting this demand while making sure that the right dosage form is provided.
Lack of finances can also be a significant challenge to manufacturing injectable pharmaceuticals.
What factors are driving trends in injectable pharmaceuticals?
The primary factor that appears to be driving trends in injectable pharmaceuticals is the increasing prevalence of chronic diseases. With more and more people falling ill with chronic conditions, demand for injectable drugs has increased.
Another key factor is the advancement in technology, which has contributed in no small way to patient compliance with injectable drugs.
Implementing innovations in injectable drug delivery
The biotech and pharmaceutical companies need to align their drug development with the several diseases and viruses that continue to spring up. Drug manufacturers worldwide invest a lot of money into this because it is a very long process that requires attention to details through the development, clinical trials, injection molding and approval stages. The clinical trial stage is by far the most complex of these stages because the drug has to be tested and properly evaluated to be sure it is efficient and safe for use by a large number of people.
What are the benefits of injectable pharmaceuticals?
Many people prefer to take injections than to swallow several pills, because the former are usually faster in action. Dosage of injectable drugs can be controlled: One of the significant challenges that are being faced by drug industries is drug abuse, where many use more than the prescribed amount of drug. Injectable pharmaceuticals can control this usage as professionals who are at the developing end of these pharmaceutical devices can control the quantity and concentration.
What are the limitations of injectable drug delivery devices?
The injectable drug delivery and injection molding industry is a highly innovative one, and that is why we have seen the development of many devices over the years. However, the sector still has limitations.
Recently, the injection molding industry has considered a move towards more customized hand-held devices that take advantage of existing platforms. The challenge, however, with this is the difficulty that comes with customizing the platforms. To successfully make use of these platforms, biotech and pharmaceutical companies need to differentiate them from existing ones to reach their target market faster.
Another major limitation of injectable drug delivery devices is the need for human factor engineering in designing hand-held devices. Getting the required skill on a larger scale has not been possible and has largely affected the industry projections with these devices' design. Human factor engineering is crucial for developing any connected drug delivery device in today's world. The human factor focuses on the essential elements of human interactions.
Limitation also exist in the form of regulatory guidance issued by government authorities. While the essence of these guidelines is to ensure there is a uniform framework that explains how human factor engineering and studies should be integrated into drug delivery devices, the process of seeking approval is lengthy and appears almost impossible for everyone other than the big biotech companies. This means that the availability of injectable drug delivery devices is only limited to big biotech and pharmaceutical companies' capacity.
What are some recent advances in injectable drug delivery technology?
Efforts are being made to design drug delivery devices and implement client needs into such design. An example of this is the drug delivery device of Duoject that not only focuses on meeting the mechanical needs, but has also developed a design methodology that ensures its devices are comprehensive, meeting different end-users' needs.
A notable delivery device of Duoject is its Vaccject – a cartridge-based device that serves as an alternative to the popular prefilled syringe. This delivery device comes with an auto-retract needle safety feature that can be separated from the device until you want to use it.
Another recent advancement that we have seen with injectable drug delivery technology is Enable injector development, which comes in a smaller and lighter size. It has a long-term container closure that is not contained in the device, so it is not as heavy as other devices. It also comes with a 'pause' function that users can make use of at any time and makes it possible for users to stop injecting the drug when they experience any pain or discomfort in the process.
Many biotech companies are working to deliver smarter and more effective auto-injectors. A significant consideration for the companies that produce such devices is the ability to customize an auto-injector to fit a particular company's portfolio.
Injectable pharmaceutical processing and packaging
After successfully manufacturing injectable pharmaceuticals, the next step is to have them processed and packaged. Over the years, we have seen several changes in how drugs are generally being packaged. Injectable drugs have not been different as they have come in various delivery systems that have changed over the years.
The most important elements of injectable pharmaceutical processing and packaging include the need for quality, good administration systems, and the best components. There is also the need to be aware of the regulatory guidelines that mitigate risk during packaging. Worthy of mention is the need for advanced technologies as this makes processing and packaging faster and more effective.
What materials are commonly used in injectable primary pharmaceutical packaging?
The most common primary materials used in injectable pharmaceutical packaging are prefillable glass syringes and vials for glass packaging. While these are the major materials for modern aseptic injectables, others are still being used. Some manufacturers use various glass container systems that help them customize the appearance of the injectable drug. These glass containers are used mainly for storing parenterals. Other materials needed in the packaging process include a container closure system, reconstitution kits, disposable syringes, ampoules, and pen systems.
Depending on the manufacturer and the type of design they look to achieve like plastic injection molding, they can also consider using other materials for drug delivery devices. However, it is imperative to consider end-users' needs when packaging these injectable drugs, especially because of the low compliance level of patients.
Injectable pharmaceuticals are drug product delivery systems that can be used as an alternative to oral drugs and are more effective because of how fast they work. Injectable pharmaceuticals are passed into the human body through syringes to the bloodstream and other parts of the body. Unlike oral drugs, injectable drugs do not get dismantled in the stomach and are not altered by digestive enzymes. There are several benefits of injectable pharmaceuticals, and that is why many biotech companies and big pharmaceuticals are keying into the many opportunities in this industry.
What are the top companies that manufacture injectable pharmaceuticals?
There are many existing companies and vendors and a lot more coming up with new syringe technology ideas. Quality, financial capacity, knowledge, and experience of the industry are all key parameters in which to judge an injectable manufacturing company.
It is almost impossible to make mention of injectable pharmaceuticals without referencing Pfizer. In 2015, the company completed its buyout of Hospira, a biosimilar company and one of the top suppliers of generic injectable drugs such as anesthesia, oncology, cardiovascular, and anti-ineffective therapies.
Other big names are Hikma, Sagent and Novartis.
What are the main challenges of manufacturing injectable pharmaceuticals?
While many patients find injectable pharmaceuticals more effective than oral medicine, injectable drugs are less convenient for patients, raising issues of adherence, even for those that are in chronic conditions.
The quest for different delivery methods is another challenge even though it is being managed with the recent growth of the global injectable drug delivery market. Patients, regardless of their state, want convenience and as a result, manufacturers are faced with the challenge of meeting this demand while making sure that the right dosage form is provided.
Lack of finances can also be a significant challenge to manufacturing injectable pharmaceuticals.
What factors are driving trends in injectable pharmaceuticals?
The primary factor that appears to be driving trends in injectable pharmaceuticals is the increasing prevalence of chronic diseases. With more and more people falling ill with chronic conditions, demand for injectable drugs has increased.
Another key factor is the advancement in technology, which has contributed in no small way to patient compliance with injectable drugs.
Implementing innovations in injectable drug delivery
The biotech and pharmaceutical companies need to align their drug development with the several diseases and viruses that continue to spring up. Drug manufacturers worldwide invest a lot of money into this because it is a very long process that requires attention to details through the development, clinical trials, injection molding and approval stages. The clinical trial stage is by far the most complex of these stages because the drug has to be tested and properly evaluated to be sure it is efficient and safe for use by a large number of people.
What are the benefits of injectable pharmaceuticals?
Many people prefer to take injections than to swallow several pills, because the former are usually faster in action. Dosage of injectable drugs can be controlled: One of the significant challenges that are being faced by drug industries is drug abuse, where many use more than the prescribed amount of drug. Injectable pharmaceuticals can control this usage as professionals who are at the developing end of these pharmaceutical devices can control the quantity and concentration.
What are the limitations of injectable drug delivery devices?
The injectable drug delivery and injection molding industry is a highly innovative one, and that is why we have seen the development of many devices over the years. However, the sector still has limitations.
Recently, the injection molding industry has considered a move towards more customized hand-held devices that take advantage of existing platforms. The challenge, however, with this is the difficulty that comes with customizing the platforms. To successfully make use of these platforms, biotech and pharmaceutical companies need to differentiate them from existing ones to reach their target market faster.
Another major limitation of injectable drug delivery devices is the need for human factor engineering in designing hand-held devices. Getting the required skill on a larger scale has not been possible and has largely affected the industry projections with these devices' design. Human factor engineering is crucial for developing any connected drug delivery device in today's world. The human factor focuses on the essential elements of human interactions.
Limitation also exist in the form of regulatory guidance issued by government authorities. While the essence of these guidelines is to ensure there is a uniform framework that explains how human factor engineering and studies should be integrated into drug delivery devices, the process of seeking approval is lengthy and appears almost impossible for everyone other than the big biotech companies. This means that the availability of injectable drug delivery devices is only limited to big biotech and pharmaceutical companies' capacity.
What are some recent advances in injectable drug delivery technology?
Efforts are being made to design drug delivery devices and implement client needs into such design. An example of this is the drug delivery device of Duoject that not only focuses on meeting the mechanical needs, but has also developed a design methodology that ensures its devices are comprehensive, meeting different end-users' needs.
A notable delivery device of Duoject is its Vaccject – a cartridge-based device that serves as an alternative to the popular prefilled syringe. This delivery device comes with an auto-retract needle safety feature that can be separated from the device until you want to use it.
Another recent advancement that we have seen with injectable drug delivery technology is Enable injector development, which comes in a smaller and lighter size. It has a long-term container closure that is not contained in the device, so it is not as heavy as other devices. It also comes with a 'pause' function that users can make use of at any time and makes it possible for users to stop injecting the drug when they experience any pain or discomfort in the process.
Many biotech companies are working to deliver smarter and more effective auto-injectors. A significant consideration for the companies that produce such devices is the ability to customize an auto-injector to fit a particular company's portfolio.
Injectable pharmaceutical processing and packaging
After successfully manufacturing injectable pharmaceuticals, the next step is to have them processed and packaged. Over the years, we have seen several changes in how drugs are generally being packaged. Injectable drugs have not been different as they have come in various delivery systems that have changed over the years.
The most important elements of injectable pharmaceutical processing and packaging include the need for quality, good administration systems, and the best components. There is also the need to be aware of the regulatory guidelines that mitigate risk during packaging. Worthy of mention is the need for advanced technologies as this makes processing and packaging faster and more effective.
What materials are commonly used in injectable primary pharmaceutical packaging?
The most common primary materials used in injectable pharmaceutical packaging are prefillable glass syringes and vials for glass packaging. While these are the major materials for modern aseptic injectables, others are still being used. Some manufacturers use various glass container systems that help them customize the appearance of the injectable drug. These glass containers are used mainly for storing parenterals. Other materials needed in the packaging process include a container closure system, reconstitution kits, disposable syringes, ampoules, and pen systems.
Depending on the manufacturer and the type of design they look to achieve like plastic injection molding, they can also consider using other materials for drug delivery devices. However, it is imperative to consider end-users' needs when packaging these injectable drugs, especially because of the low compliance level of patients.
References
Upcoming Events
-
CPHI Japan 2023
Tokyo Big Sight, Tokyo, Japan
19 - 21 April 2023 -
CPHI North America 2023
Pennsylvania Convention Center, Philadelphia
April, 25-27, 2023 -
CPHI & PMEC China 2023
Shanghai New International Expo Center
19 - 21 June 2023
Pharmaceutical Industry Webinars
-
Webinar Contract Packaging Outlook: Growth Trends within the Commercial Packaging Sector
-
25th May 2023
-
4pm CET / 10am EST
-
-
Webinar The HPAPI Boom: How Pharma is Rising to the Manufacturing Challenge
-
23rd February 2023
-
4pm CET / 10am EST
-
-
Webinar Optimal Capsule Selection for your Pharma and Nutra Products
-
15th February 2023
-
4pm CET / 10am EST
-
-
Webinar How to Commercialise an Advanced Therapy: Lessons Learned and Future Plans
-
31st January 2023
-
4pm CET / 10am EST
-
-
Webinar Creating a Circular Economy for the Pharmaceutical Packaging Industry
-
18th January 2023
-
4pm CET / 10am EST
-
-
Webinar Looking to The Future: What to Expect in the Pharmaceutical Industry in 2023
-
13th December 2022
-
4pm CET / 10am EST
-
-
Webinar Discover and Make in India: From Generic Leaders to Innovators
-
22nd November 2022
-
4pm CET / 10am EST
-
-
Webinar Innovating or Stagnating? Reviewing the Current State of Pharma in Europe
-
25th October 2022
-
4pm CET / 10am EST
-
-
Webinar Improved Delivery of Poorly Soluble Compounds Using Capsule Formulations
-
August 25th, 2022
-
4pm CET, 10am EST
-
-
Webinar Common Stumbling Blocks When Outsourcing an Injectable Project to a CMO and How to Avoid Them
-
June 28th, 2022
-
4pm CET, 10am EST
-
-
Webinar The Digitalization of Autoinjector Manufacturing Webinar
-
June 22nd, 2022
-
4pm CET, 10am EST
-
-
Webinar How Small/Mid-Size Firms are Shaping the Healthcare M&A Market
-
April 28th, 2022
-
4pm CET / 11am EST / 10am CST
-
-
Webinar Technology & Device Trends Driving Care from Hospital to Home
-
March 29th, 2022
-
4pm CET / 10am EST
-
-
Webinar Rapid Tech Transfer of Vaccine Products
-
February 24th, 2022
-
4pm CET / 10am EST / 9am CST
-
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance